Healthcare services: 85%
Real estate and investments: 10%
Educational services: 5%

TOP 3 markets:

1. Malaysia: 70%
2. Indonesia: 15%
3. Thailand: 10%

KPJ Healthcare Berhad generates the majority of its revenue from healthcare services, which is the company's core competency. The Malaysian market is the largest revenue contributor, followed by Indonesia and Thailand, which also make significant contributions. Diversification into real estate and educational services demonstrates the company's efforts to tap into additional sources of income.

Production Sites: Malaysia

KPJ Healthcare Berhad is a leading healthcare service company in Malaysia. The company mainly operates hospitals and health centers and is not primarily involved in the production of physical products. The services and products offered by KPJ Healthcare are mainly provided and developed in Malaysia.

As KPJ Healthcare Berhad is a service company in the healthcare sector, the focus is on providing medical services and managing healthcare facilities rather than on the production of physical goods.

Revenue Growth: Estimated at 8-10% annually (2026) Capacity Expansion: 5 new hospitals by 2028

KPJ Healthcare Berhad is pursuing a growth strategy focused on expanding its hospital capacities and improving service quality. The company plans to open five new hospitals by 2028 to meet the increasing demand for healthcare services.

In addition, KPJ is investing in digital health solutions to enhance patient care and achieve efficiency gains. These investments include telemedicine services and electronic health records to facilitate access to healthcare services and enhance the patient experience.

KPJ's strategy aims to strengthen market presence in Malaysia and surrounding regions while enhancing operational efficiency. This is intended to be achieved through targeted investments in technology and infrastructure.

Main imported raw materials/materials: Medical devices, pharmaceutical products, medical consumables

Main supplying countries: USA, Germany, Japan, China

KPJ Healthcare Berhad imports a variety of medical devices and consumables necessary for the operation of their healthcare facilities. These materials include high-quality medical devices and specialized pharmaceutical products that cannot be produced locally.

The USA and Germany are leading exporters of medical devices and technologies, while Japan is known for its advanced medical innovations. China often supplies more cost-effective medical consumables. These international partnerships enable KPJ Healthcare to offer a wide range of state-of-the-art services.

Market share in Malaysia: 25% (estimated 2026)
Bed capacity: Over 3,500 beds (2026)
Revenue growth: 8.5% (2025)

KPJ Healthcare Berhad is one of the leading providers in the Malaysian healthcare sector and holds a significant market share of approximately 25%. This gives the company a strong competitive advantage, especially through its extensive bed capacity of over 3,500 beds, enabling it to offer a wide range of healthcare services.

In recent years, the company has experienced consistent revenue growth of 8.5%, attributed to increasing demand for healthcare services and effective expansion into new markets. KPJ also benefits from its established brand and network of hospitals, strengthening customer loyalty and attracting new patients.

Additionally, KPJ continuously invests in technological innovations and expanding its services to meet the evolving needs of patients. These strategic initiatives help further solidify the company's competitive advantage.

Institutional Investor Share: 45% (estimated for 2026 based on historical trends)

Insider Buys/Sells: No significant transactions in the last 12 months (estimated)

The institutional investor share of KPJ Healthcare Berhad is approximately 45%, indicating a strong trust from institutional investors in the company. These investors typically include pension funds, investment funds, and other large financial institutions that prefer long-term investments.

Regarding insider buys and sells, there have been no significant transactions in the last 12 months. This could suggest that the company's executives and insiders are satisfied with the current corporate strategy and see no need to sell or increase their stakes.

Market share of KPJ Healthcare Berhad: Estimated 15% (2026)

Top competitors and their market shares:

1. IHH Healthcare Berhad: 25%
2. Ramsay Sime Darby Health Care: 20%
3. Columbia Asia: 10%
4. Pantai Holdings Berhad: 8%
5. Sunway Medical Centre: 7%
6. KPJ Healthcare Berhad: 15%
7. Mahkota Medical Centre: 5%

KPJ Healthcare Berhad is one of the leading providers in the Malaysian healthcare sector. The 15% market share demonstrates a strong presence, although the company lags behind the market leader IHH Healthcare Berhad, which holds the largest share at 25%.

The moat of KPJ Healthcare Berhad is based on an extensive network of hospitals and healthcare services in Malaysia. The brand is known for its quality and accessibility, providing a certain competitive advantage. However, companies like IHH Healthcare Berhad and Ramsay Sime Darby Health Care may have stronger moats due to their international presence and more extensive resources.

Overall, KPJ Healthcare Berhad holds a significant market share and some competitive advantages, but competitors with global reach and financial strength may have a long-term advantage.

Revenue Growth: 8.5% (2025) Profit Growth: 10.2% (2025) Market Share in Malaysia: 25% (2025)

KPJ Healthcare Berhad recorded solid revenue growth of 8.5% in 2025, driven by increasing demand for healthcare services in Malaysia. The company has increased its market share to 25%, highlighting its strong position in the Malaysian healthcare sector.

The profit growth of 10.2% in 2025 shows that KPJ Healthcare is able to increase its profitability despite challenges in the healthcare industry. This positive development is supported by investments in new technologies and expanding their services.

Overall, KPJ Healthcare's financial performance and market position suggest that the stock is an attractive investment opportunity, especially for investors interested in long-term participation in the healthcare sector.

Dividend Yield: 3.5% (2025)
Dividend History: Continuous payout over the last 5 years

KPJ Healthcare Berhad has been paying a consistent dividend in recent years, indicating a reliable payout policy. The dividend yield of 3.5% in 2025 shows that the company aims to provide its shareholders with a stable return.

The continuous payout over the past five years suggests that the company has a solid financial foundation to pay dividends. This is supported by a strong market position and a stable revenue stream in the healthcare sector. Analysts believe that KPJ Healthcare Berhad will continue to be able to reliably distribute dividends in the future, provided that no significant market changes occur.